about
Repositioning FDA-Approved Drugs in Combination with Epigenetic Drugs to Reprogram Colon Cancer Epigenome.Hepatocyte Factor JMJD5 Regulates Hepatitis B Virus Replication through Interaction with HBxDepletion of JMJD5 sensitizes tumor cells to microtubule-destabilizing agents by altering microtubule stability.JMJD5 is a human arginyl C-3 hydroxylase.
P2860
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
JMJD5 is a potential oncogene for colon carcinogenesis.
@ast
JMJD5 is a potential oncogene for colon carcinogenesis.
@en
type
label
JMJD5 is a potential oncogene for colon carcinogenesis.
@ast
JMJD5 is a potential oncogene for colon carcinogenesis.
@en
prefLabel
JMJD5 is a potential oncogene for colon carcinogenesis.
@ast
JMJD5 is a potential oncogene for colon carcinogenesis.
@en
P2093
P2860
P1476
JMJD5 is a potential oncogene for colon carcinogenesis
@en
P2093
Qingjun Huang
Yingxue Li
Yinpeng Li
P2860
P304
P577
2015-06-01T00:00:00Z